Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of effectiveness and therapeutic response to Preductal OD 80 mg in daily practical use for chronic stable angina pectoris

Trial Profile

Evaluation of effectiveness and therapeutic response to Preductal OD 80 mg in daily practical use for chronic stable angina pectoris

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Aug 2018

At a glance

  • Drugs Trimetazidine (Primary)
  • Indications Angina pectoris; Coronary artery disease
  • Focus Therapeutic Use
  • Acronyms ODA
  • Sponsors Servier
  • Most Recent Events

    • 23 Aug 2018 New trial record
    • 13 Aug 2018 Results published in the Advances in Therapy
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top